Yahoo Web Search

Search results

1. • 

     Is Intellia Therapeutics Stock a Buy Now?

     Motley Fool via Yahoo Finance· 3 months ago

     Many investors were skeptical of biotechs specializing in gene editing three years ago. Though some had made clinical progress, few had launched any...

2. • 

     Analysts Say Intellia Therapeutics Stock Could Rise 157% This Year, but Will It Happen?

     Motley Fool via Yahoo Finance· 3 months ago

     Wall Street analysts are quite bullish about Intellia Therapeutics (NASDAQ: NTLA) stock. On average,...

3. • 

     Intellia Therapeutics (NASDAQ:NTLA) Is In A Good Position To Deliver On Growth Plans

     Simply Wall St. via Yahoo Finance· 10 months ago

     Just because a business does not make any money, does not mean that the stock will go down. For...

4. • 

     Is It Too Late to Buy Intellia Therapeutics Stock?

     Motley Fool via Yahoo Finance· 4 months ago

     Companies focusing on developing gene editing therapies have made significant progress over the past year. However, that has done little to keep Intellia...

5. • 

     Intellia Therapeutics, Inc. (NTLA) Reports Q3 Loss, Lags Revenue Estimates

     Zacks via Yahoo Finance· 2 years ago

     Intellia Therapeutics, Inc. (NTLA) delivered earnings and revenue surprises of -13.74% and 2.48%,...

6. • 

     Intellia Therapeutics Stock Has 119% Upside, According to 1 Wall Street Analyst

     Motley Fool via Yahoo Finance· 3 months ago

     The day after Intellia Therapeutics (NASDAQ: NTLA) updated investors with its results for the fourth...

7. • 

     Does Intellia Therapeutics (NASDAQ:NTLA) Have A Healthy Balance Sheet?

     Simply Wall St. via Yahoo Finance· 2 years ago

     Some say volatility, rather than debt, is the best way to think about risk as an investor, but...

8. • 

     Intellia Therapeutics Inc (NTLA) Reports Q3 2023 Financial Results and Progress in CRISPR Therapies

     GuruFocus.com via Yahoo Finance· 7 months ago

     Intellia Therapeutics Inc (NASDAQ:NTLA) announced FDA clearance for NTLA-2001 IND application,...

9. • 

     Is Intellia Therapeutics, Inc. (NASDAQ:NTLA) Trading At A 25% Discount?

     Simply Wall St. via Yahoo Finance· 5 months ago

     Key Insights The projected fair value for Intellia Therapeutics is US$40.78 based on 2 Stage Free...

10. • 

      Investors bid Intellia Therapeutics (NASDAQ:NTLA) up US$290m despite increasing losses YoY, taking...

      Simply Wall St. via Yahoo Finance· 2 years ago

      It hasn't been the best quarter for Intellia Therapeutics, Inc. (NASDAQ:NTLA) shareholders, since...